Has Anthony Meluch received payments from drug or device companies?

Yes. Drug and device makers reported $80,410 in general payments to Anthony Meluch across 277 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anthony Meluch did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anthony Meluch come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anthony Meluch

Hematology & Oncology · Nashville, TNNPI 1679521090

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $58,823 of the $80,410 with a category attached, or 73.2%. Exelixis Inc. accounts for 91.0% of it on its own, with 48 other manufacturers making up the rest. Reporting peaked in 2019 at $57,775 and has fallen 99.9% since, to $50 in 2024.

$80,410in general payments, 2019–2025

Across 277 payments — averaging $290.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Exelixis Inc.$73K
Sanofi$2K
AVEO Pharmaceuticals, Inc.$1K
Merck$469
AstraZeneca$340
E.r. Squibb & Sons, L.L.C.$291
plus $3K from 43 others

What the payments were for

Consulting fees$2,9104%
Speaking & faculty fees$58,82373%
Travel & lodging$12,34515%
Food & beverage$6,3088%
Education$230%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Exelixis Inc.	72	$73,195
Sanofi	9	$2,113
AVEO Pharmaceuticals, Inc.	3	$1,148
Merck	19	$469
AstraZeneca(2 entities)	12	$340
E.r. Squibb & Sons, L.L.C.	12	$291
Novartis	14	$249
Johnson & Johnson	13	$229
Amgen	11	$223
Genentech USA, Inc.	7	$200
Pharmacyclics LLC, An Abbvie Company	7	$125
Regeneron Healthcare Solutions, Inc.	5	$114
Bayer	5	$111
Gilead(2 entities)	7	$111
Astellas Pharma US Inc	6	$102
Pfizer	7	$95
Eisai Inc.	4	$83
Lilly USA, LLC	5	$80
Seagen Inc.	5	$80
Bristol Myers Squibb	4	$79
Incyte Corporation	5	$78
G1 Therapeutics, Inc.	3	$70
Tesaro, Inc.	2	$68
Teva Pharmaceuticals USA, Inc.	4	$62
Takeda Pharmaceuticals U.S.A., Inc.	3	$59
Array Biopharma Inc	3	$58
Karyopharm Therapeutics Inc.	1	$49
Daiichi Sankyo Inc.	2	$48
Rigel Pharmaceuticals, Inc.	3	$46
Biocompatibles, Inc.	2	$44
EMD Serono, Inc.	2	$41
AbbVie	2	$40
Blueprint Medicines Corporation	2	$37
Deciphera Pharmaceuticals Inc.	1	$27
Morphosys, US Inc.	1	$21
Jazz Pharmaceuticals Inc.	1	$21
GSK	1	$20
Beigene USA, Inc.	1	$20
Pharmaessentia USA Corporation	1	$19
Mirati Therapeutics, Inc.	1	$16
Puma Biotechnology, Inc.	1	$16
Mylan Institutional Inc.	1	$16
Tersera Therapeutics LLC	1	$16
CTI Biopharma Corp.	1	$15
Dova Pharmaceuticals	1	$15
Partner Therapeutics, Inc.	1	$15
Ipsen Biopharmaceuticals, Inc	1	$14
Verastem, Inc.	1	$12
AMAG Pharmaceuticals, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Cabometyx$72,476
JEVTANA$1,910
FOTIVDA$1,127
OPDIVO$125
KEYTRUDA$121
LYNPARZA$103

How this compares

$80,410 in reported general payments places this provider in the 85th percentile of 251 hematology & oncology providers in Tennessee.

See all hematology & oncology providers in Tennessee →

Other hematology & oncology in Nashville

Jonathan AbbasNashville$1.3M
Alan TanNashville$1.1M
Kent ShihNashville$900K
Brian RiniNashville$601K
Wade IamsNashville$601K
Krish PatelNashville$531K
Sandeep RajanNashville$465K
Todd BauerNashville$357K
Muhamed BaljevicNashville$313K
Olalekan OluwoleNashville$311K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →